IP Library Granted Patent US 11,633,626
Granted Patent B2
US 11,633,626 · App. 17/235,812 · Granted Apr 25, 2023

Methods for real-time image guided radiation therapy

Inventors: Yevgen Voronenko (San Jose, CA); Peter Demetri Olcott (Los Gatos, CA); Debashish Pal (Sunnyvale, CA); Rostem Bassalow (Port Orchard, WA)
Assignee: RefleXion Medical, Inc.
A61N5/1067A61N5/1036A61N5/1039A61N5/1049A61N5/1071A61N5/1081A61N5/1068A61N2005/1052A61N2005/1055A61N2005/1061A61N2005/1091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,633,626
App. No.
17/235,812
Filed
Apr 20, 2021
Granted
Apr 25, 2023
Kind
B2
Art Unit
2884
USPC
378/65
Abstract

Disclosed herein are systems and methods for guiding the delivery of therapeutic radiation using incomplete or partial images acquired during a treatment session. A partial image does not have enough information to determine the location of a target region due to, for example, poor or low contrast and/or low SNR. The radiation fluence calculation methods described herein do not require knowledge or calculation of the target location, and yet may help to provide real-time image guided radiation therapy using arbitrarily low SNR images.

Claims (24)

1. A method for calculating a radiation dose for radiotherapy, the method comprising:

acquiring a partial image x i of a target region using at least one positron emission detector;

calculating a radiation fluence F i to be delivered to the target region based on the partial image x i and a radiation-firing matrix P; and

calculating a radiation dose using the calculated radiation fluence F i and a computed tomography (CT) image.

2. The method of claim 1 , further comprising comparing the calculated radiation dose with a planned radiation dose.

3. The method of claim 1 , further comprising generating a graphical representation of the calculated radiation dose.

4. The method of claim 1 , wherein calculating the radiation fluence comprises multiplying the radiation-firing matrix P and the partial image x i (F i =P·x i ), wherein the radiation-firing matrix P is calculated based on a previously-acquired image X of the target region.

5. The method of claim 1 , wherein the CT image is a CT image acquired during a diagnostic imaging session.

6. The method of claim 2 , wherein calculating the radiation fluence F i comprises multiplying the radiation-firing matrix P and the partial image x i (F i =P·x i ), wherein the radiation-firing matrix P is calculated based on a previously-acquired image X of the target region, and wherein the method further comprises modifying the radiation-firing matrix P after comparing the calculated radiation dose with the planned radiation dose.

7. The method of claim 1 , further comprising comparing the calculated radiation fluence with a planned radiation fluence.

8. The method of claim 1 , wherein the partial image x i comprises positron emission activity data.

9. The method of claim 8 , wherein the positron emission activity data comprises one or more of PET data, lines-of-responses (LOR) data, and PET detector signals.

10. The method of claim 9 , wherein the LOR data and/or PET detector signals comprise simulated LOR data and/or PET detector signals.

11. The method of claim 1 , further comprising emitting the calculated radiation fluence to a phantom, and measuring radiation emitted to the phantom.

12. The method of claim 11 , further comprising calculating a delivered fluence map based on the measured radiation and comparing the delivered fluence map with a planned fluence map.

13. The method of claim 11 , further comprising calculating a delivered dose map based on the measured radiation, and comparing the delivered dose map with a planned dose map.

14. The method of claim 13 , further comprising determining, based on the comparison between the delivered dose map and the planned dose map, whether a treatment plan meets specified quality criteria.

15. The method of claim 14 , further comprising calculating a distance to agreement (DTA) value of fluence isodoses and an absolute dose difference between the delivered dose map and the planned dose map for multiple time points, determining whether a percentage of time points that are within a DTA value and within a specified absolute dose difference threshold is greater than a threshold percentage, and generating a notification based on whether the percentage of time points is greater than a threshold percentage.

16. The method of claim 15 , wherein the threshold percentage is about 95%, the DTA value is about 3 mm, and the specified absolute dose difference threshold is about 3% from a planned absolute dose.

17. The method of claim 14 , wherein determining whether the treatment plan meets specified quality criteria comprises calculating a gamma metric that combines a DTA value of fluence isodoses and an absolute dose difference between the delivered dose map, and generating a notification of whether the calculated gamma metric meets a threshold gamma level.

18. The method of claim 11 , wherein the partial image x i comprises positron emission activity data.

19. The method of claim 18 , wherein the positron emission activity data comprises one or more of PET data, lines-of-responses (LOR) data, and PET detector signals.

20. The method of claim 19 , wherein the LOR data and/or PET detector signals comprise simulated LOR data and/or PET detector signals.

21. The method of claim 4 , wherein a signal to noise ratio (SNR) of the partial image x i of the target region is less than a SNR of the previously-acquired image X of the target region.

Assignments (2)
SECURITY INTEREST Recorded Jul 11, 2022
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 060619/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2021
From: VORONENKO, YEVGEN; OLCOTT, PETER DEMETRI; PAL, DEBASHISH; BASSALOW, ROSTEM
To: REFLEXION MEDICAL, INC.
Reel/Frame 055993/0632 →
Continuity (5)
Continuation 16554258 · Aug 28, 2019
Continuation 15993325 · May 30, 2018
Provisional Application 62537384 · Jul 26, 2017
Provisional Application 62512632 · May 30, 2017
Related Publication 20210236854A1 · Aug 5, 2021
Cited By (11)
US 12,214,219 US 12,251,579 US 12,268,895 US 12,303,718 US 12,337,196 US 12,420,115 US 12,502,554 US 12,521,571 US 12,551,725 US 12,582,845 US 12,700,100